| 2024 | | Inhibition of Toll-like Receptors Alters Macrophage Cholesterol Efflux and Foam Cell Formation | 김지연, 김지원, 김현아, 변혜은, 서창희, 정주양 |
| 2024 | | Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2024 | | Role of chemokines CXCL9, CXCL10, CXCL11, and CXCR3 in the serum and minor salivary gland tissues of patients with Sjögren’s syndrome | 김지원, 김현아, 서창희, 정주양, 한재호 |
| 2024 | | Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | 서창희 |
| 2024 | | Clinical characteristics and prognostic factors of non-tuberculous mycobacterial disease in patients with rheumatoid arthritis | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2023 | | Biosimilars in the treatment of rheumatoid arthritis: a pharmacokinetic overview | 서창희 |
| 2023 | | Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | Rosuvastatin treatment alone cannot alleviate lupus in murine model: A pilot study | 서창희 |
| 2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination | 김지원, 김현아, 서창희, 예영민, 정주양 |
| 2023 | | Association between CCR2 and CCL2 expression and NET stimulation in adult-onset Still’s disease | 김지원, 김현아, 서창희, 정주양, 한재호 |
| 2023 | | Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2023 | | Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | The transcription factor Mef2d regulates B:T synapse–dependent GC-TFH differentiation and IL-21–mediated humoral immunity | 김지원, 서창희 |
| 2023 | | Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data | 서창희 |
| 2022 | | Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis | 서창희 |
| 2022 | | Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | Correlations between salivary gland scintigraphy and histopathologic data of salivary glands in patients with primary Sjogren’s syndrome | 강정현, 김지원, 김현아, 노진, 서창희, 안영실, 정주양, 한재호 |
| 2022 | | Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool | 김지원, 김현아, 박성훈, 서창희, 정주양 |
| 2022 | | Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus Erythematosus | 김현아, 서창희, 정주양 |
| 2022 | | Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study | 김지원, 부선주, 서창희 |
| 2022 | | Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis | 서창희 |
| 2022 | | S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | Publisher Correction: Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still’s disease | 권지은, 김지원, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2022 | | Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still’s disease | 권지은, 김지원, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2022 | | Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study | 서창희 |
| 2022 | | Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus: Case report | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | Flare of adult-onset Still’s disease following mRNA COVID-19 vaccination: a case report and review of literature | 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a Mus musculus Model | 서창희 |
| 2021 | | Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83 | 김현아, 서창희, 손성향, 유혜명, 정주양 |
| 2021 | | Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review | 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Toll‐like receptor signaling inhibitory peptide improves inflammation in animal model and human systemic lupus erythematosus | 서창희 |
| 2021 | | An update on the pathogenic role of neutrophils in systemic juvenile idiopathic arthritis and adult-onset still’s disease | 김지원, 김현아, 서창희, 안미현, 정주양 |
| 2021 | | Salivary immunoglobulin gamma-3 chain c is a promising noninvasive biomarker for systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2021 | | Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature | 김영배, 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus | 서창희 |
| 2021 | | Lupus low disease activity state achievement is important for reducing adverse outcomes in pregnant patients with systemic lupus erythematosus | 곽동욱, 김지원, 김현아, 서창희, 양정인, 정주양 |
| 2021 | | Impact of infliximab biosimilar ct-p13 dose and infusion interval on real-world drug survival and effectiveness in patients with ankylosing spondylitis | 서창희 |
| 2021 | | The assessment of muscle mass and function in patients with long-standing rheumatoid arthritis | 김지원, 김춘자, 김현아, 서창희, 정주양 |
| 2021 | | Anti-inflammatory effects of low-dose glucocorticoids compensate for their detrimental effects on bone mineral density in patients with rheumatoid arthritis | 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis | 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Real-world observational study of biosimilars in inflammatory arthritis treatment: a systematic literature review | 김지원, 서창희, 정주양 |
| 2021 | | Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still's disease | 김지원, 김현아, 서창희, 정주양 |
| 2020 | | COMPARISON OF INFLAMMATORY MARKERS AS DIAGNOSTIC TOOL IN PATIENTS WITH ADULT-ONSET STILL'S DISEASE | 김지원, 김현아, 서창희, 정주양 |
| 2020 | | DISEASE ACTIVITY IS IMPORTANT RISK FACTORS FOR MATERNAL AND FETAL OUTCOMES DURING PREGNANCY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | 김지원, 김현아, 서창희, 정주양 |
| 2020 | | SEASONAL VARIATIONS AND ASSOCIATED FACTORS OF GOUT ATTACKS: A PROSPECTIVE MULTICENTER STUDY IN SOUTH KOREA | 김현아, 서창희, 정주양 |
| 2020 | | A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis | 서창희 |
